These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9927691)

  • 1. The stretch-activation response may be critical to the proper functioning of the mammalian heart.
    Vemuri R; Lankford EB; Poetter K; Hassanzadeh S; Takeda K; Yu ZX; Ferrans VJ; Epstein ND
    Proc Natl Acad Sci U S A; 1999 Feb; 96(3):1048-53. PubMed ID: 9927691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ablation of the N terminus of cardiac essential light chain promotes the super-relaxed state of myosin and counteracts hypercontractility in hypertrophic cardiomyopathy mutant mice.
    Sitbon YH; Kazmierczak K; Liang J; Yadav S; Veerasammy M; Kanashiro-Takeuchi RM; Szczesna-Cordary D
    FEBS J; 2020 Sep; 287(18):3989-4004. PubMed ID: 32034976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrete effects of A57G-myosin essential light chain mutation associated with familial hypertrophic cardiomyopathy.
    Kazmierczak K; Paulino EC; Huang W; Muthu P; Liang J; Yuan CC; Rojas AI; Hare JM; Szczesna-Cordary D
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H575-89. PubMed ID: 23748425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The overall pattern of cardiac contraction depends on a spatial gradient of myosin regulatory light chain phosphorylation.
    Davis JS; Hassanzadeh S; Winitsky S; Lin H; Satorius C; Vemuri R; Aletras AH; Wen H; Epstein ND
    Cell; 2001 Nov; 107(5):631-41. PubMed ID: 11733062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular biology and pathophysiology of hypertrophic cardiomyopathy due to mutations in the beta myosin heavy chains and the essential and regulatory light chains.
    Epstein ND
    Adv Exp Med Biol; 1998; 453():105-14; discussion 114-5. PubMed ID: 9889820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged Ca2+ and force transients in myosin RLC transgenic mouse fibers expressing malignant and benign FHC mutations.
    Wang Y; Xu Y; Kerrick WG; Wang Y; Guzman G; Diaz-Perez Z; Szczesna-Cordary D
    J Mol Biol; 2006 Aug; 361(2):286-99. PubMed ID: 16837010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant familial hypertrophic cardiomyopathy D166V mutation in the ventricular myosin regulatory light chain causes profound effects in skinned and intact papillary muscle fibers from transgenic mice.
    Kerrick WG; Kazmierczak K; Xu Y; Wang Y; Szczesna-Cordary D
    FASEB J; 2009 Mar; 23(3):855-65. PubMed ID: 18987303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myosin regulatory light chain E22K mutation results in decreased cardiac intracellular calcium and force transients.
    Szczesna-Cordary D; Jones M; Moore JR; Watt J; Kerrick WG; Xu Y; Wang Y; Wagg C; Lopaschuk GD
    FASEB J; 2007 Dec; 21(14):3974-85. PubMed ID: 17606808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and functional aspects of the myosin essential light chain in cardiac muscle contraction.
    Muthu P; Wang L; Yuan CC; Kazmierczak K; Huang W; Hernandez OM; Kawai M; Irving TC; Szczesna-Cordary D
    FASEB J; 2011 Dec; 25(12):4394-405. PubMed ID: 21885653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis of physiological versus pathological cardiac remodeling in animal models expressing mutations in myosin essential light chains.
    Gomes AV; Kazmierczak K; Cheah JX; Gilda JE; Yuan CC; Zhou Z; Szczesna-Cordary D
    J Muscle Res Cell Motil; 2015 Dec; 36(6):447-61. PubMed ID: 26668058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac contractility, motor function, and cross-bridge kinetics in N47K-RLC mutant mice.
    Wang L; Kazmierczak K; Yuan CC; Yadav S; Kawai M; Szczesna-Cordary D
    FEBS J; 2017 Jun; 284(12):1897-1913. PubMed ID: 28467684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of slow skeletal troponin I in adult transgenic mouse heart muscle reduces the force decline observed during acidic conditions.
    Wolska BM; Vijayan K; Arteaga GM; Konhilas JP; Phillips RM; Kim R; Naya T; Leiden JM; Martin AF; de Tombe PP; Solaro RJ
    J Physiol; 2001 Nov; 536(Pt 3):863-70. PubMed ID: 11691878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice.
    Szczesna-Cordary D; Guzman G; Zhao J; Hernandez O; Wei J; Diaz-Perez Z
    J Cell Sci; 2005 Aug; 118(Pt 16):3675-83. PubMed ID: 16076902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceleration of stretch activation in murine myocardium due to phosphorylation of myosin regulatory light chain.
    Stelzer JE; Patel JR; Moss RL
    J Gen Physiol; 2006 Sep; 128(3):261-72. PubMed ID: 16908724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the N-terminus of the myosin essential light chain in cardiac muscle contraction.
    Kazmierczak K; Xu Y; Jones M; Guzman G; Hernandez OM; Kerrick WG; Szczesna-Cordary D
    J Mol Biol; 2009 Apr; 387(3):706-25. PubMed ID: 19361417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo analysis of an essential myosin light chain mutation linked to familial hypertrophic cardiomyopathy.
    Sanbe A; Nelson D; Gulick J; Setser E; Osinska H; Wang X; Hewett TE; Klevitsky R; Hayes E; Warshaw DM; Robbins J
    Circ Res; 2000 Aug; 87(4):296-302. PubMed ID: 10948063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myosin light chain replacement in the heart.
    Sanbe A; Gulick J; Hayes E; Warshaw D; Osinska H; Chan CB; Klevitsky R; Robbins J
    Am J Physiol Heart Circ Physiol; 2000 Sep; 279(3):H1355-64. PubMed ID: 10993803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in mice.
    Yuan CC; Muthu P; Kazmierczak K; Liang J; Huang W; Irving TC; Kanashiro-Takeuchi RM; Hare JM; Szczesna-Cordary D
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4138-46. PubMed ID: 26124132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E22K mutation of RLC that causes familial hypertrophic cardiomyopathy in heterozygous mouse myocardium: effect on cross-bridge kinetics.
    Dumka D; Talent J; Akopova I; Guzman G; Szczesna-Cordary D; Borejdo J
    Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2098-106. PubMed ID: 16751284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanical and energetic properties of papillary muscle from ACTC E99K transgenic mouse models of hypertrophic cardiomyopathy.
    Song W; Vikhorev PG; Kashyap MN; Rowlands C; Ferenczi MA; Woledge RC; MacLeod K; Marston S; Curtin NA
    Am J Physiol Heart Circ Physiol; 2013 Jun; 304(11):H1513-24. PubMed ID: 23604709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.